Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Frederiksberg, Denmark Clinical Trials

A listing of Frederiksberg, Denmark clinical trials actively recruiting patients volunteers.

RESULTS

Found (658) clinical trials

The Effect of Palm Olein Olive Oil and Lard and on Risk Markers of Cardiovascular Disease

The aim of this study is to compare the effects of a diet rich in palm olein, a fraction of palm oil, to a diet rich in olive oil and a diet rich in Danish lard on plasma total-, LDL and HDL cholesterol as well as triacylglycerol (TAG), fasting insulin ...

Phase N/A

1.31 miles

Learn More »

The Effect of Calcium on Fecal Fat and Energy Excretion

Several reports have found inverse associations between calcium intake and body weight. Few intervention studies have shown that a high calcium diet resulted in a greater body weight loss than a low calcium diet. The mechanism is not clear, but one possible explanation is reduced absorption of fat in the ...

Phase N/A

1.31 miles

Learn More »

Encapsulated Nutrients' Acute Effects on Appetite; ENcapSulated nUtRiEnts (ENSURE)

For standardization, 48 hours before the test days, the participants will be asked to consume a regular diet compliant to what they usually eat and no excessive alcohol consumption (not above 5 units and no alcohol at all from 8 pm the night before the test days) or intense physical ...

Phase N/A

1.31 miles

Learn More »

Stress and Eating Behavior Among University Students - an Randomized Controlled Trial

STUDY METHODS Study design: The study is a randomized controlled two-armed cross-over intervention study. The study is carried out in 50 healthy university students, both genders. In random order the participants will be investigated during stressful-period (prior to an exam) and a non-stressful (control period) period. Each participant will take ...

Phase N/A

1.31 miles

Learn More »

The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS

Background Disruption of the blood brain barrier (BBB) is believed to play a critical role in the pathogenesis of multiple sclerosis (MS). Cramer et al. (2014) found increased BBB permeability in MS patients compared to healthy controls (HC) with values being higher in cases with recent relapses (1). Furthermore, BBB ...

Phase N/A

1.31 miles

Learn More »

Platine Avastin and OLAparib in 1st Line

Patients with advanced FIGO stage IIIB - IV high grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer treated with standard first-line treatment, combining platinum-taxane chemotherapy and bevacizumab concurrent with chemotherapy and in maintenance.

Phase

1.38 miles

Learn More »

A School-Based Intervention to Improve Social Functioning

Background In 2013, the former Danish minister of Social Affairs presented a national plan for the help and treatment of people with ADHD. Acknowledging the rise in the number of citizens in Denmark with an ADHD diagnosis, the Danish government supported an enhanced effort to offer this group adequate treatment. ...

Phase N/A

1.38 miles

Learn More »

Effects of Partical Excavation in One Versus Two Procedures of Primary Deep Caries (PAPRICA)

Originality of the project: The originality of the PAPRICA project will be to provide high-quality clinical evidence for optimal treatment of deep caries lesions which is urgently needed. The project is very relevant within an area that has been known for suggestions of many treatments with the most invasive ones ...

Phase N/A

1.56 miles

Learn More »

A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer

The purpose of this international, phase 2, open-label, response rate study of talazoparib is to assess the efficacy and safety of talazoparib in men with DNA repair defects metastatic castration-resistant prostate cancer (CRPC) who previously received taxane-based chemotherapy and progressed on at least 1 novel hormonal agent (enzalutamide and/or abiraterone ...

Phase

1.73 miles

Learn More »

A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

This study is an international phase 3 randomized, open-label, parallel group efficacy and safety study to evaluate oral daily relugolix 120 mg in patients with androgen-sensitive advanced prostate cancer who require at least 1 year (48 weeks) of continuous androgen deprivation therapy. Relugolix 120 mg orally once daily or leuprolide ...

Phase

1.73 miles

Learn More »